NCT05974410 2025-10-02
Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients
AVM Biotechnology Inc
Available
AVM Biotechnology Inc
Children's Oncology Group
Children's Oncology Group
Memorial Sloan Kettering Cancer Center